Next Article in Journal
Predictive Biomarkers for Outcomes of Immune Checkpoint Inhibitors (ICIs) in Melanoma: A Systematic Review
Next Article in Special Issue
Azacitidine Plus Venetoclax for the Treatment of Relapsed and Newly Diagnosed Acute Myeloid Leukemia Patients
Previous Article in Journal
The Effects of Physical Activity on Cancer Patients Undergoing Treatment with Immune Checkpoint Inhibitors: A Scoping Review
 
 
Review

Article Versions Notes

Cancers 2021, 13(24), 6365; https://doi.org/10.3390/cancers13246365
Action Date Notes Link
article xml file uploaded 18 December 2021 11:17 CET Original file -
article xml uploaded. 18 December 2021 11:17 CET Update https://www.mdpi.com/2072-6694/13/24/6365/xml
article pdf uploaded. 18 December 2021 11:17 CET Version of Record https://www.mdpi.com/2072-6694/13/24/6365/pdf
article html file updated 18 December 2021 11:18 CET Original file -
article html file updated 30 July 2022 23:07 CEST Update https://www.mdpi.com/2072-6694/13/24/6365/html
Back to TopTop